Provided by Tiger Trade Technology Pte. Ltd.

Tango Therapeutics Inc.

22.91
+0.33501.48%
Volume:80.71K
Turnover:1.83M
Market Cap:3.87B
PE:-27.27
High:22.92
Open:22.60
Low:22.44
Close:22.57
52wk High:34.39
52wk Low:6.69
Shares:169.00M
Float Shares:121.00M
Volume Ratio:0.23
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8400
EPS(LYR):-0.8746
ROE:-21.34%
ROA:-12.99%
PB:3.78
PE(LYR):-26.19

Loading ...

Tango Therapeutics - Vopimetostat Plus Daraxonrasib Generally Well Tolerated With No New Safety Signals

THOMSON REUTERS
·
Jun 08

Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer

THOMSON REUTERS
·
Jun 08

Tango Therapeutics - to Advance Vopimetostat Plus Daraxonrasib Into Phase 3 for Mtap-Deleted Pancreatic Cancer

THOMSON REUTERS
·
Jun 08

A Look At Tango Therapeutics (TNGX) Valuation As Optimism Builds Around Upcoming Pancreatic Cancer Data

Simply Wall St.
·
Jun 07

Tango Therapeutics grants new hire 170,000-share stock option at $23.1, awards 40,000 RSUs

Reuters
·
Jun 05

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 05

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 05

Tango Therapeutics shareholders elected two Class II directors at annual meeting

Reuters
·
Jun 05

Tango Therapeutics President, R&D Crystal Adam disposes of USD 618,289 in common shares

Reuters
·
Jun 04

Stifel Nicolaus Sticks to Its Buy Rating for Tango Therapeutics (TNGX)

TIPRANKS
·
May 18

Assessing Tango Therapeutics (TNGX) Valuation After Trial Progress And Leadership Changes

Simply Wall St.
·
May 16

Tango Therapeutics falls -14.9%

TIPRANKS
·
May 15

Stock Track | Tango Therapeutics Plummets 10.11% Intraday Following Analyst Rating Downgrade

Stock Track
·
May 15

Tango Therapeutics Inc : Mizuho Raises Target Price to $30 From $20

THOMSON REUTERS
·
May 15

Stock Track | Tango Therapeutics Plunges 9.73% in Pre-Market on Analyst Downgrades

Stock Track
·
May 15

U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific

Reuters
·
May 15

Stock Track | Tango Therapeutics Plummets 10.82% Intraday Following Jefferies Downgrade to Hold

Stock Track
·
May 15

Stock Track | Tango Therapeutics Plunges 6.7% in Pre-market Following Jefferies Downgrade to Hold

Stock Track
·
May 14

Stifel Nicolaus Sticks to Their Buy Rating for Tango Therapeutics (TNGX)

TIPRANKS
·
May 14

Tango Therapeutics Inc : Jefferies Cuts to Hold From Buy; Raises Target Price to $27 From $18

THOMSON REUTERS
·
May 14